These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin. Onyike CU; Bonner JO; Lyketsos CG; Treisman GJ Am J Psychiatry; 2004 Mar; 161(3):429-35. PubMed ID: 14992966 [No Abstract] [Full Text] [Related]
5. [Alpha-interferon and mental disorders]. Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D Encephale; 2001; 27(4):308-17. PubMed ID: 11686052 [TBL] [Abstract][Full Text] [Related]
6. Interferon for hepatitis C patients with psychiatric disorders. Wilson MS Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569921 [No Abstract] [Full Text] [Related]
7. Managing the neuropsychiatric complications of hepatitis C treatment. Sockalingam S; Shammi C; Stergiopoulos V Br J Hosp Med (Lond); 2007 Oct; 68(10):520-5. PubMed ID: 17974293 [TBL] [Abstract][Full Text] [Related]
8. Case of mania induced by withdrawal of interferon-alpha in a patient affected by bipolar disorder. Rossi A; Renzetti D; D'Albenzio L; Gianfelice D; Kalyvoka A; Rinaldi O Psychiatry Clin Neurosci; 2002 Dec; 56(6):647-8. PubMed ID: 12485309 [No Abstract] [Full Text] [Related]
9. [Mania induced by interferon alpha in a patient with an acute viral hepatitis B]. Oueslati B; Moula O; Jelalia I; Tounsi AA; Triki R; Ghachem R Presse Med; 2018 Apr; 47(4 Pt 1):408-409. PubMed ID: 29555165 [No Abstract] [Full Text] [Related]
10. Mania as a presentation of primary hypothyroidism. Sathya A; Radhika R; Mahadevan S; Sriram U Singapore Med J; 2009 Feb; 50(2):e65-7. PubMed ID: 19296014 [TBL] [Abstract][Full Text] [Related]
11. Mania induced by withdrawal of treatment with interferon alfa. Carpiniello B; Orru MG; Baita A; Pariante CM; Farci G Arch Gen Psychiatry; 1998 Jan; 55(1):88-9. PubMed ID: 9435767 [No Abstract] [Full Text] [Related]
12. The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation. van Zonneveld M; Flink HJ; Verhey E; Senturk H; Zeuzem S; Akarca US; Cakaloglu Y; Simon C; So TM; Gerken G; de Man RA; Hansen BE; Schalm SW; Janssen HL; Aliment Pharmacol Ther; 2005 May; 21(9):1163-71. PubMed ID: 15854180 [TBL] [Abstract][Full Text] [Related]
13. [Psychotic disorders induced by interferon alfa]. D'Innella P; Zaccala G; Terazzi M; Olgiati P; Torre E Recenti Prog Med; 2002 Jun; 93(6):367-9. PubMed ID: 12085716 [TBL] [Abstract][Full Text] [Related]
14. Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C. Crone CC; Gabriel GM; Wise TN Cleve Clin J Med; 2004 May; 71 Suppl 3():S27-32. PubMed ID: 15468615 [TBL] [Abstract][Full Text] [Related]
16. Expect psychiatric side effects from corticosteroid use in the elderly. Cerullo MA Geriatrics; 2008 Jan; 63(1):15-8. PubMed ID: 18257615 [TBL] [Abstract][Full Text] [Related]
17. Use of antipsychotic drugs and lithium in mania. Cookson J Br J Psychiatry Suppl; 2001 Jun; 41():s148-56. PubMed ID: 11450176 [TBL] [Abstract][Full Text] [Related]
18. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo. Goldberg JF; Calabrese JR; Saville BR; Frye MA; Ketter TA; Suppes T; Post RM; Goodwin FK J Clin Psychiatry; 2009 Sep; 70(9):1273-80. PubMed ID: 19689918 [TBL] [Abstract][Full Text] [Related]